Evaluation of an algorithm for switching from IV to PO therapy in clinical practice in patients with community-acquired pneumonia
- 1 February 2004
- journal article
- Published by Elsevier in Clinical Therapeutics
- Vol. 26 (2) , 294-303
- https://doi.org/10.1016/s0149-2918(04)90028-8
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Early Switch and Early Discharge Strategies in Patients With Community-Acquired PneumoniaArchives of internal medicine (1960), 2001
- Early transition to oral antibiotic therapy for community-acquired pneumonia: duration of therapy, clinical outcomes, and cost analysisRespiratory Medicine, 1998
- Sequential Therapy With Cefuroxime Followed by Cefuroxime Axetil in Community-Acquired PneumoniaChest, 1997
- A Prediction Rule to Identify Low-Risk Patients with Community-Acquired PneumoniaNew England Journal of Medicine, 1997
- A Prospective Randomized Study of Inpatient IV Antibiotics for Community-Acquired PneumoniaChest, 1996
- Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysisJAMA, 1996
- Oral versus intravenous antibiotics for community acquired lower respiratory tract infection in a general hospital: open, randomised controlled trialBMJ, 1995
- Efficacy and tolerance of cefotaxime followed by oral cefixime versus cefotaxime alone in patients with lower respiratory tract infectionsCurrent Therapeutic Research, 1994
- Parenteral-Oral Switch in the Management of Paediatric PneumoniaDrugs, 1994
- Cefuroxime and cefuroxime axetil versus amoxicillin plus clavulanic acid in the treatment of lower respiratory tract infectionsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1992